Christopher Mehlin

This inventor holds 29 USPTO granted patents and 31 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Antibody Engineering. Top assignees: Amgen Inc., Fred Hutchinson Cancer Center, Amgen K-a, Inc.. Active years: 2010-2024.

USPTO Granted Patents = 29 (Patent Applications = 31)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 5.6

ph-index = 11

Forward Citations = 314(Granted Patents)

Company Filing History:

Fred Hutchinson Cancer Center

Blaze Bioscience, Inc.

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Anti-CD33 Antibodies

IL-17 Receptor A

Antigen Binding Proteins

Proprotein Convertase Subtilisin Kexin Type 9

Cartilage-Homing Peptides

Monoclonal Antibodies

Thymic Stromal Lymphopoietin

Anti-Mesothelin

Neutralizing Antibodies

Psoriasis Treatment

Inflammatory Disorders

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12116406 - Anti-CD33 antibodies and uses thereof (2024-10-15),

2. 11987640 - Anti-mesothelin antigen-binding molecules and uses thereof (2024-05-21),

3. 11981745 - Anti-mesothelin antigen-binding molecules and uses thereof (2024-05-14),

4. 11858999 - IL-17 receptor A antigen binding proteins (2024-01-02),

5. 11648290 - Cartilage-homing peptides (2023-05-16),

6. 11180564 - IL-17 Receptor A antigen binding proteins (2021-11-23),

7. 11090358 - Cartilage-homing peptides (2021-08-17),

8. 10287348 - Antigen binding proteins capable of binding thymic stromal lymphopoietin (2019-05-14),

9. 10208122 - IL-17 receptor A antigen binding proteins (2019-02-19),

10. 10156559 - Lipocalin fusion partners (2018-12-18),

11. 9920134 - Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9) (2018-03-20),

12. 9493576 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) (2016-11-15),

13. 9315577 - Anti-hepcidin antibodies and methods of use (2016-04-19),

14. 9284372 - Antigen binding proteins capable of binding thymic stromal lymphopoietin (2016-03-15),

15. 9073999 - Anti-IL-17 receptor A neutralizing antibodies (2015-07-07),

Title: The Innovative Journey of Christopher Mehlin

Introduction: Christopher Mehlin is a pioneering inventor based in Seattle, WA. His passion for innovation has led to groundbreaking developments in various fields.

Latest Patents: Christopher Mehlin's latest patents include advancements in renewable energy technology, sustainable agriculture solutions, and cutting-edge healthcare devices.

Career Highlights: With a career spanning over two decades, Christopher Mehlin has established himself as a leading figure in the world of inventions. His work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout his career, Christopher Mehlin has collaborated with top research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the successful implementation of many groundbreaking ideas.

Conclusion: Christopher Mehlin's dedication to innovation and his relentless pursuit of excellence continue to inspire inventors and entrepreneurs worldwide. His contributions have significantly shaped the landscape of modern technology and will continue to do so for years to come.